Related Experiment Video
Updated: Sep 13, 2025
Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
Published on: November 28, 2018
Predictive value of early postoperative copeptin after cardiac surgery: A two-centre prospective cohort study
Anna Kirkopoulos1, Irsa Salehi, René M'Pembele
1From the Department of Anesthesiology, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany (AK, RM, PM, AS, TT, DD, RH, DK-M, GLB, SR), Department of Anesthesiology and Intensive Care Medicine, University Hospital Essen, University Duisburg-Essen, Essen, Germany (IS, AH, JB, SD, TB, MMB), Department of Anesthesiology, Intensive Care Medicine, Emergency Medicine and Pain Medicine, RKH Hospital Ludwigsburg, Ludwigsburg, Germany (MMB), Department of Anesthesiology, Kerckhoff Klinik, Bad Nauheim, Germany (RH).
Background:
Patients undergoing cardiac surgery are at increased risk for postoperative complications, making early postoperative risk evaluation crucial. Recent studies have shown that copeptin, a neurohumoral marker, is associated with major adverse events after noncardiac surgery. However, data on its role after cardiac surgery are scarce.
Objective:
Primary aim of this study was to analyse the association of early postoperative copeptin levels with adverse events after cardiac surgery.
Design:
Observational, prospective cohort study.
Setting:
Two German tertiary healthcare centres. Enrolment took place between March 2021 and August 2022.
Patients:
Adults undergoing elective on-pump cardiac surgery were included.
Main Outcome Measures:
Main exposure was early postoperative copeptin. Primary outcome was new-onset disability 1 year after surgery, as defined by a World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) score of ≥16% or an increase of ≥5% in case of pre-operative disability.
Results:
295 out of 363 prospectively enrolled patients were included in the final analysis (28.8% female, median [IQR] age 64 years, [56 to 71]. Fifty-four patients (18.3%) developed new-onset disability and 3.4% (10/295) died within 1 year. Logistic regression analysis showed an adjusted odds ratio (aOR) of 2.35 (95% confidence interval, 'CI', 1.17 to 4.72) for the association between elevated copeptin and new-onset disability. The discrimination of copeptin for new-onset disability was weak and did not improve risk stratification when added to the pre-operative EuroSCORE II and postoperative troponin (ROC AUC EuroSCOREII+troponin+copeptin = 0.685, 95% CI 0.61 to 0.76; ROC AUC EuroSCOREII+troponin = 0.678, 95% CI 0.59 to 0.76, DeLong test: P = 0.82). DeLong test: P = 0.82).
Conclusion:
Early postoperative copeptin is independently associated with new-onset disability at 1 year after cardiac surgery. Due to weak discrimination for new-onset disability routine measurement of copeptin cannot be recommended.
Trial Registration:
Clinicaltrials.gov identifier: NCT04877795.
Related Concept Videos
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
01:30Acute Coronary Syndrome III: Diagnostic Studies